Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice. The earlier Revision: v3.4.1 notice was also removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedNotice about a lapse in government funding and status updates (top-of-page notice) has been added, and the site revision note has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary toggle and QC metadata (Last Update Submitted that Met QC Criteria) along with revision information (Revision: v3.4.0). The previous labels and older revision (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) are removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocation sections were updated to include North Carolina and Kerala as study sites, and the page revision was updated to v3.3.3. The previous placement of these locations was removed in the v3.3.2 update.SummaryDifference0.3%

- Check85 days agoChange DetectedThe page shows a new revision tag, v3.3.2, replacing v3.3.1. No study data or eligibility information is affected.SummaryDifference0.1%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.